logo
Plus   Neg
Share
Email

CVS Health Updates 2018 Adj. Operating Profit Growth - Quick Facts

CVS Health Corp. (CVS) updated its previous adjusted consolidated operating profit growth guidance of 1.0% to 4.0% for the full-year 2018 to down 1.5% to up 1.5%. The company revised its 2018 guidance to reflect the effects of the tax reform achieved through the Tax Cuts and Jobs Act. In addition to debt reduction, the company is dedicating a portion of the benefits to additional investments in employees, data analytics, care management solutions, and service offering enhancements, a portion of which will be capitalized. The impact to the company's 2018 consolidated operating profit is expected to be at least $275 million. The company expects to deliver adjusted consolidated operating profit growth of 0.5% to 4.5% for the first quarter of 2018.

Consolidated operating profit for the three months ended December 31, 2017, increased 3.6%, to $3.1 billion. The company said the increase was partially due to improvement in gross profit in the Pharmacy Services Segment as result of a favorable shift in the timing of Medicare Part D profits between the third and fourth quarters of 2017, when compared to 2016, as well as growth in network and specialty volume, and favorable purchasing economics. The Retail/LTC Segment gross profit increased, largely driven by improvements in front store margin. The improvements in operating profit were also due to a $50 million decrease in acquisition-related transaction and integration costs as well as a $30 million decrease in store rationalization costs.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Nvidia Corp. (NVDA) Thursday reported a surge in its second-quarter profit, driven largely by a better-than-expected growth in revenues and strong margins. However, shares of the graphics chip maker slipped about 4 percent in extended session, as its revenue outlook for the current quarter fell short... The U.S. Food and Drug Administration Thursday approved the first generic version of Mylan's EpiPen for the emergency treatment of allergic reactions. Teva Pharmaceuticals gained the US regulator's approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths. Shares of... Amazon.com Inc. (AMZN) is reportedly planning to acquire Landmark Theatres, as the e-commerce giant seeks to gain a foothold in the brick-and-mortar cinema industry. Bloomberg Thursday reported, citing people familiar with the situation, that Amazon is looking with other suitors to acquire the business...
Follow RTT